Lexeo Therapeutics, Inc. Common Stock Balance Sheet
Concept
Total Assets
Current Assets
Cash, Cash Equivalents & Short Term Investments
Cash & Equivalents
Other Short Term Investments
Receivables
Inventory
Other Current Assets
Total non-current assets
Property, Plant & Equipment
Long-Term Investments
Total Liabilities
Current Liabilities
Accounts Payable
Current Debt
Deferred Revenue
Total Non Current Liabilities Net Minority Interest
Long-Term Debt
Other Long-Term Liabilities
Common Stock Equity
Working Capital
Invested Capital
Total Debt
Net Debt
2023
2022
2021
2020
140M
124M
121M
0M
0M
0M
0M
0M
16M
0M
0M
26M
17M
4M
3M
11M
9M
0M
0M
114M
107M
114M
12M
-110M
97M
80M
77M
0M
0M
0M
0M
0M
17M
0M
0M
210M
14M
3M
3M
9M
196M
0M
0M
-113M
66M
-113M
13M
-64M
137M
137M
136M
0M
0M
0M
0M
1M
0M
0M
0M
192M
7M
3M
4M
0M
185M
0M
0M
-56M
129M
-56M
0M
-136M
29M
29M
29M
0M
0M
0M
0M
0M
0M
0M
0M
35M
1M
0M
1M
0M
34M
0M
0M
-6M
29M
-6M
0M
-29M
Concept
Total Assets
Current Assets
Cash, Cash Equivalents & Short Term Investments
Cash & Equivalents
Other Short Term Investments
Receivables
Inventory
Other Current Assets
Total non-current assets
Property, Plant & Equipment
Long-Term Investments
Total Liabilities
Current Liabilities
Accounts Payable
Current Debt
Deferred Revenue
Total Non Current Liabilities Net Minority Interest
Long-Term Debt
Other Long-Term Liabilities
Common Stock Equity
Working Capital
Invested Capital
Total Debt
Net Debt
4Q2023
3Q2023
2Q2023
4Q2022
2Q2022
140M
124M
121M
0M
0M
0M
0M
0M
16M
0M
0M
26M
17M
4M
3M
11M
9M
0M
0M
114M
107M
114M
12M
-110M
55M
39M
35M
0M
0M
0M
0M
2M
16M
0M
0M
218M
23M
3M
7M
13M
194M
0M
0M
-163M
16M
-159M
16M
-19M
65M
49M
46M
0M
0M
0M
0M
1M
16M
0M
0M
209M
14M
2M
3M
7M
195M
0M
0M
-144M
35M
-144M
13M
-33M
97M
80M
77M
0M
0M
0M
0M
0M
17M
0M
0M
210M
14M
3M
3M
9M
196M
0M
0M
-113M
66M
-113M
13M
-64M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M